Cargando…
Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic
OBJECTIVE: No data are available to develop uniform recommendations for reperfusion therapies in ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to fill the evidence gap regarding STEMI reperfusion strategy during the COVID-19 era....
Autores principales: | Wang, Nan, Zhang, Min, Su, Huajun, Huang, Zhonglue, Lin, Yongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645389/ https://www.ncbi.nlm.nih.gov/pubmed/33108941 http://dx.doi.org/10.1177/0300060520966151 |
Ejemplares similares
-
Primary PCI: a reasonable treatment for STEMI care during the COVID-19 pandemic
por: Jimenez Melo, O, et al.
Publicado: (2021) -
Underutilization of Fibrinolysis Despite Timely Arrival in STEMI: A Missed Opportunity!
por: Gnanaraj, Justin Paul, et al.
Publicado: (2023) -
Thrombus aspiration during primary percutaneous coronary intervention
improved outcome in patients with STEMI and a large thrombus
burden
por: Bin, Ning, et al.
Publicado: (2021) -
Impact of COVID-19 on STEMI: Second youth for fibrinolysis or time to centralized approach?
por: Tumminello, Gabriele, et al.
Publicado: (2020) -
Reply: Underutilization of Fibrinolysis Despite Timely Arrival in STEMI: A Missed Opportunity!
por: Bhatia, Kirtipal, et al.
Publicado: (2023)